当前位置:首页 - 行情中心 - 可孚医疗(301087) - 财务分析 - 现金流量表

可孚医疗

(301087)

  

流通市值:100.35亿  总市值:122.03亿
流通股本:1.94亿   总股本:2.36亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,136,204,049.241,030,430,502.743,547,757,870.922,498,112,040.76
  收到的税费返还12,120,494.138,862,595.6913,997,403.976,876,263.9
  收到其他与经营活动有关的现金99,097,678.378,560,994.31217,811,788.2131,316,723.21
  经营活动现金流入小计2,247,422,221.671,117,854,092.743,779,567,063.092,636,305,027.87
  购买商品、接受劳务支付的现金820,033,259.74439,847,845.671,272,894,109.25879,005,212.06
  支付给职工以及为职工支付的现金345,041,642.59174,014,836.43592,169,856.54460,308,253.44
  支付的各项税费119,870,989.1244,792,571.17259,835,475.54163,166,593.65
  支付其他与经营活动有关的现金700,065,014.53356,638,706.58958,941,805.05543,833,580.53
  经营活动现金流出小计1,985,010,905.981,015,293,959.853,083,841,246.382,046,313,639.68
  经营活动产生的现金流量净额262,411,315.69102,560,132.89695,725,816.71589,991,388.19
二、投资活动产生的现金流量:
  收回投资收到的现金800,110,000150,110,0002,224,008,802.81,274,344,499
  取得投资收益收到的现金8,853,742.311,857,619.2239,227,559.0921,314,112.75
  处置固定资产、无形资产和其他长期资产收回的现金净额288,755.1419,283.2118,201,990.618,661,081.62
  处置子公司及其他营业单位收到的现金净额--6,861,725.026,861,725.02
  收到的其他与投资活动有关的现金---539,362.45
  投资活动现金流入小计809,252,497.45151,986,902.432,288,300,077.521,311,720,780.84
  购建固定资产、无形资产和其他长期资产支付的现金81,404,145.8233,529,360.49178,096,173.4160,657,696.53
  投资支付的现金405,076,876309,359,714.312,046,035,996.661,184,147,380.59
  取得子公司及其他营业单位支付的现金--133,127,977.7133,127,977.7
  投资活动现金流出小计486,481,021.82342,889,074.82,357,260,147.761,477,933,054.82
  投资活动产生的现金流量净额322,771,475.63-190,902,172.37-68,960,070.24-166,212,273.98
三、筹资活动产生的现金流量:
  吸收投资收到的现金909,929,239.53-24,555,100700,000
  其中:子公司吸收少数股东投资收到的现金--700,000700,000
  取得借款收到的现金987,549,729.87667,044,378.361,156,408,202.171,023,077,709.36
  收到其他与筹资活动有关的现金--65,468,747.93112,861,632.21
  筹资活动现金流入小计1,897,478,969.4667,044,378.361,246,432,050.11,136,639,341.57
  偿还债务支付的现金932,292,457.96457,359,945.51,249,657,568.61951,002,360.38
  分配股利、利润或偿付利息支付的现金250,347,691.441,152,506.76371,775,036.32367,040,359.37
  支付其他与筹资活动有关的现金228,501,769.8318,563,140.8493,746,229.71168,444,572.68
  筹资活动现金流出小计1,411,141,919.23477,075,593.11,715,178,834.641,486,487,292.43
  筹资活动产生的现金流量净额486,337,050.17189,968,785.26-468,746,784.54-349,847,950.86
四、汇率变动对现金及现金等价物的影响-15,314,840.11-3,225,998.04-3,429,799.77-2,049,743.68
五、现金及现金等价物净增加额1,056,205,001.3898,400,747.74154,589,162.1671,881,419.67
  加:期初现金及现金等价物余额1,294,575,300.71,294,575,300.71,139,986,138.541,139,986,138.54
  期末现金及现金等价物余额2,350,780,302.081,392,976,048.441,294,575,300.71,211,867,558.21
补充资料:
  净利润203,199,082.13-370,316,214.99-
  资产减值准备17,885,514.95-33,823,806.65-
  固定资产和投资性房地产折旧55,086,735.31-106,719,689.39-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧55,086,735.31-106,719,689.39-
  无形资产摊销5,270,603.05-9,650,182.73-
  长期待摊费用摊销9,245,332.07-24,064,148.46-
  处置固定资产、无形资产和其他长期资产的损失-599,369.13-1,369,618.79-
  固定资产报废损失141,633.81-462,668.86-
  公允价值变动损失-19,846,399.43--49,842,350.95-
  财务费用22,680,656.64-19,566,475.28-
  投资损失5,184,896.42--15,844,585.29-
  递延所得税-1,345,716.24--2,835,072.62-
  其中:递延所得税资产减少-2,200,744.3-4,449,431.56-
    递延所得税负债增加855,028.06--7,284,504.18-
  存货的减少-129,176,815.78-34,111,573.35-
  经营性应收项目的减少-96,032,043.58--20,766,290.51-
  经营性应付项目的增加146,667,249.53-85,629,969.85-
  其他10,417,134.28-31,700,376.04-
  现金的期末余额2,350,780,302.08-1,294,575,300.7-
  减:现金的期初余额1,294,575,300.7-1,139,986,138.54-
  现金及现金等价物的净增加额1,056,205,001.38-154,589,162.16-
公告日期2026-08-292026-04-302026-03-102025-10-30
审计意见(境内)标准无保留意见
TOP↑